Atlas Trials

Feasibility Study of Intraperitoneal Bevacizumab for Palliation of Intractable Malignant Ascites

Clinical trial NCT02496286 · TERMINATED

Trial details

NCT number
NCT02496286
Sponsor
Eastern Regional Medical Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Ascites
Start date
2015-06-01
Primary completion
2015-08-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.